HPV-associated lung cancers: An international pooled analysis

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1267-1275

  Ragin, Camille ^a   Obikoya Malomo, Monisola ^a   Kim, Sungjin ^b   Chen, Zhengjia ^b   Flores Obando, Rafael ^c   Gibbs, Denise ^a   Koriyama, Chihaya ^d   Aguayo, Francisco ^e   Koshiol, Jill ^f   Caporaso, Neil E ^f   Carpagnano, Giovanna E ^g   Ciotti, Marco ^h   Dosaka Akita, Hirotoshi ⁱ   Fukayama, Masashi ^j   Goto, Akiteru ^j   Spandidos, Demetrios A ^k   Gorgoulis, Vassilis ^l   Heideman, Daniëlle A M ^m   van Boerdonk, Robert A A ^m   Hiroshima, Kenzo ⁿ   Iwakawa, Reika ^o   Kastrinakis, Nikolaos G ^l   Kinoshita, Ichiro ⁱ   Akiba, Suminori ^d   Landi, Maria T ^f   Liu, H Eugene ^p   Wang, Jinn Li ^p   Mehra, Ranee ^a   Khuri, Fadlo R ^q   Lim, Wan Teck ^r   Owonikoko, Taofeek K ^q   Ramalingam, Suresh ^q   Sarchianaki, Emmanuela ^k   Syrjanen, Kari ^s,t   Tsao, Ming Sound ^u   Sykes, Jenna ^u   Hee, Siew Wan ^v   Yokota, Jun ^o   Zaravinos, Apostolos ^k   Taioli, Emanuela ^w   more..

^a FOX CHASE CANCER CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF CHILE   (Chile)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF FOGGIA   (Italy)

^h TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

ⁱ HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k UNIVERSITY OF CRETE   (Greece)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^o NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^p TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^q EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^s TURKU UNIVERSITY HOSPITAL   (Finland)

^t Barretos Cancer Hospital Pio XII Foundation   (Brazil)

^u PRINCESS MARGARET HOSPITAL   (Canada)

^v UNIVERSITY OF WARWICK   (United Kingdom)

^w FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER PATIENT; CANCER RISK; CAUCASIAN; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA INTEGRATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOUTH AND CENTRAL AMERICA; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; WART VIRUS; ALPHAPAPILLOMAVIRUS; GENETICS; GENOTYPE; LUNG TUMOR; META ANALYSIS; MIDDLE AGED; VERY ELDERLY; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; VIRUS INTEGRATION;

EID: 84905092087     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu038     Document Type: Article

References (72)

1. Gillison, M.L. et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst., 92, 709-720.
2. zur Hausen, H. (1996) Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta, 1288, F55-F78.
3. Syrjänen, K.J. (1979) Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration., 38, 299-304.
4. Syrjänen, K.J. (2002) HPV infections and lung cancer. J. Clin. Pathol., 55, 885-891.
5. Klein, F. et al. (2009) Incidence of human papilloma virus in lung cancer. Lung Cancer, 65, 13-18.
6. Srinivasan, M. et al. (2009) Human papillomavirus type 16 and 18 in primary lung cancers-a meta-analysis. Carcinogenesis, 30, 1722-1728.
7. Syrjänen, K. (2012) Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res., 32, 3235-3250.
8. Miyagi, J. et al. (2000) Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J. Clin. Pathol., 53, 676-684.
9. Miyagi, J. et al. (2001) Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology, 38, 355-367.
10. Gorgoulis, V.G. et al. (1998) Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am. J. Pathol., 153, 1749-1765.
11. Gorgoulis, V.G. et al. (1999) Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum. Pathol., 30, 274-283.
12. Ciotti, M. et al. (2006) Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol. Rep., 16, 183-189.
13. Giuliani, L. et al. (2007) Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer, 57, 273-281.
14. Syrjänen, K. et al. (1989) Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization. Lung, 167, 33-42.
15. Syrjänen, K.J. et al. (1987) Human papillomavirus DNA in bronchial squamous cell carcinomas. Lancet, 1, 168-169.
16. Cheng, Y.W. et al. (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res., 61, 2799-2803.
17. Cheng, Y.W. et al. (2004) Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. Lung Cancer, 46, 165-170.
18. Cheng, Y.W. et al. (2007) Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res., 67, 10686-10693.
19. Hu, K. et al. (1997) Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 11, 147-149.
20. Li, Q. et al. (1995) Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin. Med. J. (Engl)., 108, 610-614.
21. Thomas, P. et al. (1995) Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction. Cell. Mol. Biol. (Noisy-le-grand)., 41, 1093-1097.
22. Thomas, P. et al. (1996) Detection of human papillomavirus by polymerase chain reaction in primary lung carcinoma. Bull. Cancer, 83, 842-846.
23. Wang, J. et al. (2006) Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan. Cancer Lett., 235, 18-25.
24. Yu, Y. et al. (2009) Correlation of HPV-16/18 infection of human papillomavirus with lung squamous cell carcinomas in Western China. Oncol. Rep., 21, 1627-1632.
25. Yu, Y. et al. (2013) Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas. Clin. Respir. J., 7, 27-33.
26. Hirayasu, T. et al. (1996) Human papillomavirus DNA in squamous cell carcinoma of the lung. J. Clin. Pathol., 49, 810-817.
27. Iwamasa, T. et al. (2000) Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol. Res. Pract., 196, 209-218.
28. Tung, M.C. et al. (2013) Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer. Cancer, 119, 3367-3376.
29. Liu, H.R. et al. (1994) A study of human papillary virus infection by in situ hybridization and histopathology in squamous cell carcinoma of the lung. Zhonghua Bing Li Xue Za Zhi, 23, 299-301.
30. Xing, L.Q. et al. (1994) Analysis of the characteristics of human papilloma virus infection in 85 neoplasms of the respiratory system in adult patients. Zhonghua Zhong Liu Za Zhi, 16, 424-427.
31. Pillai, R.N. et al. (2013) Human papillomavirus (HPV)-associated early stage non-small cell lung cancer (NSCLC). ASCO Meeting Abstracts, Chicago IL, 31, Abstract no. 7560.
32. Mehra, R. et al. (2013) A pilot study of the association and prevalence of the human papillomavirus (HPV) in non-small cell lung cancer (NSCLC). AACR Meeting Abstracts, Washington, DC., Abstract no. 4785.
33. Béjui-Thivolet, F. et al. (1990) Detection of human papillomavirus DNA in squamous bronchial metaplasia and squamous cell carcinomas of the lung by in situ hybridization using biotinylated probes in paraffin-embedded specimens. Hum. Pathol., 21, 111-116.
34. Carpagnano, G.E. et al. (2011) HPV in exhaled breath condensate of lung cancer patients. Br. J. Cancer, 105, 1183-1190.
35. Fei, Y. et al. (2006) Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China. Jpn. J. Clin. Oncol., 36, 274-279.
36. Galvan, A. et al. (2012) Testing of human papillomavirus in lung cancer and non-tumor lung tissue. BMC Cancer, 12, 512.
37. Gatta, L.B. et al. (2012) Human papillomavirus DNA and p16 gene in squamous cell lung carcinoma. Anticancer Res., 32, 3085-3089.
38. Joh, J. et al. (2010) Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp. Mol. Pathol., 89, 222-226.
39. Krikelis, D. et al. (2010) Frequent presence of incomplete HPV16 E7 ORFs in lung carcinomas: memories of viral infection. J. Clin. Virol., 49, 169-174.
40. Nadji, S.A. et al. (2007) Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett., 248, 41-46.
41. Niyaz, H. et al. (2000) Detection and significance of HPV16, 18 infection, P53 overexpression and telomerase activity in patients with lung cancer. Zhonghua Jie He He Hu Xi Za Zhi, 23, 679-682.
42. Wang, Y.H. et al. (2010) The relationship among human papilloma virus infection, survivin, and p53 gene in lung squamous carcinoma tissue. Saudi Med. J., 31, 1331-1336.
43. Xu, Y. et al. (2009) The Relationship between the Status of Human Papillomavirus 16/18 Infection and the Expression of Bcl-2 and Bax in Squamous Cell Carcinomas of the Lung. Zhongguo Fei Ai Za Zhi, 12, 849-852.
44. Yang, Y. et al. (2008) Association of the XRCC1 and hOGG1 polymorphisms with the risk of laryngeal carcinoma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 25, 211-213.
45. Bohlmeyer, T. et al. (1998) Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am. J. Respir. Cell Mol. Biol., 18, 265-269.
46. Nuorva, K. et al. (1995) p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int. J. Cancer, 64, 424-429.
47. Tsuhako, K. et al. (1998) Human papillomavirus DNA in adenosquamous carcinoma of the lung. J. Clin. Pathol., 51, 741-749.
48. Aguayo, F. et al. (2007) Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br. J. Cancer, 97, 85-91.
49. Baba, M. et al. (2010) Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol. Rep., 23, 1085-1092.
50. Castillo, A. et al. (2006) Human papillomavirus in lung carcinomas among three Latin American countries. Oncol. Rep., 15, 883-888.
51. Goto, A. et al. (2011) Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. J. Med. Virol., 83, 1383-1390.
52. Hiroshima, K. et al. (1999) Ultrastructural study of intranuclear inclusion bodies of pulmonary adenocarcinoma. Ultrastruct. Pathol., 23, 383-389.
53. Iwakawa, R. et al. (2010) Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma. Cancer Sci., 101, 1891-1896.
54. Koshiol, J. et al. (2011) Assessment of human papillomavirus in lung tumor tissue. J. Natl. Cancer Inst., 103, 501-507.
55. Syrjänen, K. et al. (2012) Detection of human papillomavirus genotypes in bronchial cancer using sensitive multimetrix assay. Anticancer Res., 32, 625-631.
56. Lim, W.T. et al. (2009) Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinoma. Oncol. Rep., 21, 971-975.
57. Kinoshita, I. et al. (1995) Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br. J. Cancer, 71, 344-349.
58. Wang, J.L. et al. (2014) Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma. Int. J. Cancer, 134, 65-71.
59. van Boerdonk, R.A. et al. (2013) High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis. J. Thorac. Oncol., 8, 711-718.
60. Yanagawa, N. et al. (2013) Human papilloma virus genome is rare in North American non-small cell lung carcinoma patients. Lung Cancer, 79, 215-220.
61. Behera, M. et al. (2013) Survival analysis of patients with stage I nonsmall-cell lung cancer using clinical and DNA repair pathway expression variables. Clin. Lung Cancer, 14, 128-138.
62. Peitsaro, P. et al. (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol., 40, 886-891.
63. Raghunathan, T.E. et al. (2001) A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv. Meth., 27, 85-95.
64. Branica, B.V. et al. (2010) Detection of human papillomaviruses type 16, 18 and 33 in bronchial aspirates of lung carcinoma patients by polymerase chain reaction: a study of 84 cases in Croatia. Coll. Antropol., 34, 159-162.
65. Park, M.S. et al. (2007) The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med. J., 48, 69-77.
66. Ang, K.K. et al. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med., 363, 24-35.
67. Muñoz, J.P. et al. (2012) Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells. PLoS One, 7, e38178.
68. Mehta, H. et al. (2008) Cigarette smoking and innate immunity. Inflamm. Res., 57, 497-503.
69. Pagano, J.S. et al. (2004) Infectious agents and cancer: criteria for a causal relation. Semin. Cancer Biol., 14, 453-471.
70. Ragin, C.C. et al. (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and metaanalysis. Int. J. Cancer, 121, 1813-1820.
71. Rietbergen, M.M. et al. (2013) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann. Oncol., 24, 2740-2745.
72. Lont, A.P. et al. (2006) Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int. J. Cancer, 119, 1078-1081.